{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,11,9]],"date-time":"2022-11-09T08:46:40Z","timestamp":1667983600427},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2014,3,13]],"date-time":"2014-03-13T00:00:00Z","timestamp":1394668800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Familial Cancer"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1007\/s10689-014-9706-7","type":"journal-article","created":{"date-parts":[[2014,3,12]],"date-time":"2014-03-12T05:03:45Z","timestamp":1394600625000},"page":"423-430","source":"Crossref","is-referenced-by-count":3,"title":["Attitudes and compliance of clinical management after genetic testing for hereditary breast and ovarian cancer among high-risk Southern Chinese females with breast cancer history"],"prefix":"10.1007","volume":"13","author":[{"given":"Ava","family":"Kwong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annie Tsz-Wai","family":"Chu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine Teen-Sum","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Desiree Man-Sik","family":"Tse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,3,13]]},"reference":[{"key":"9706_CR1","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1471-2407-11-6","volume":"11","author":"M Wevers","year":"2011","unstructured":"Wevers M, Ausems M, Verhoef S, Bleiker E, Hahn D, Hogervorst F, van der Luijt R, Valdimarsdottir H, van Hillegersberg R, Rutgers E, Aaronson N (2011) Behavioral and psychosocial effects of rapid genetic counseling and testing in newly diagnosed breast cancer patients: design of a multicenter randomized clinical trial. BMC Cancer 11:6","journal-title":"BMC Cancer"},{"key":"9706_CR2","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1086\/375033","volume":"72","author":"A Antoniou","year":"2003","unstructured":"Antoniou A, Pharoah PDP, Narod S, Risch HA, Eyfjord JE, Hopper JL, Loman N, Olsson H, Johannsson O, Borg \u00c5, Pasini B, Radice P, Manoukian S, Eccles DM, Tang N, Olah E, Anton-Culver H, Warner E, Lubinski J, Gronwald J, Gorski B, Tulinius H, Thorlacius S, Eerola H, Nevanlinna H, Syrj\u00e4koski K, Kallioniemi OP, Thompson D, Evans C, Peto J, Lalloo F, Evans DG, Easton DF (2003) Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 72:1117\u20131130","journal-title":"Am J Hum Genet"},{"key":"9706_CR3","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1086\/301749","volume":"62","author":"D Ford","year":"1998","unstructured":"Ford D, Easton DF, Stratton M, Narod S, Goldgar D, Devilee P, Bishop DT, Weber B, Lenoir G, Chang-Claude J, Sobol H, Teare MD, Struewing J, Arason A, Scherneck S, Peto J, Rebbeck TR, Tonin P, Neuhausen S, Barkardottir R, Eyfjord J, Lynch H, Ponder BAJ, Gayther SA, Birch JM, Lindblom A, Stoppa-Lyonnet D, Bignon Y, Borg A, Hamann U, Haites N, Scott RJ, Maugard CM, Vasen H, Seitz S, Cannon-Albright LA, Schofield A, Zelada-Hedman M (1998) Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. Am J Hum Genet 62:676\u2013689","journal-title":"Am J Hum Genet"},{"key":"9706_CR4","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1126\/science.1088759","volume":"302","author":"M-C King","year":"2003","unstructured":"King M-C, Marks JH, Mandell JB, Group TNYBCS (2003) Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science 302:643\u2013646","journal-title":"Science"},{"key":"9706_CR5","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1002\/(SICI)1097-0142(19960601)77:11<2318::AID-CNCR21>3.0.CO;2-Z","volume":"77","author":"EB Claus","year":"1996","unstructured":"Claus EB, Schildkraut JM, Thompson WD, Risch NJ (1996) The genetic attributable risk of breast and ovarian cancer. Cancer 77:2318\u20132324","journal-title":"Cancer"},{"key":"9706_CR6","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.radonc.2007.01.001","volume":"82","author":"MA Bollet","year":"2007","unstructured":"Bollet MA, Sigal-Zafrani B, Mazeau V, Savignoni A, de la Rochefordi\u00e8re A, Vincent-Salomon A, Salmon R, Campana F, Kirova YM, Dendale R, Fourquet A (2007) Age remains the first prognostic factor for loco-regional breast cancer recurrence in young (<40\u00a0years) women treated with breast conserving surgery first. Radiother Oncol 82:272\u2013280","journal-title":"Radiother Oncol"},{"key":"9706_CR7","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1093\/jnci\/89.3.227","volume":"89","author":"DA Berry","year":"1997","unstructured":"Berry DA, Parmigiani G, Sanchez J, Schildkraut J, Winer E (1997) Probability of carrying a mutation of breast-ovarian cancer gene BRCA1 based on family history. J Natl Cancer Inst 89:227\u2013238","journal-title":"J Natl Cancer Inst"},{"key":"9706_CR8","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1200\/JCO.1999.17.3.1040","volume":"17","author":"LG Bluman","year":"1999","unstructured":"Bluman LG, Rimer BK, Berry DA, Borstelmann N, Iglehart JD, Regan K, Schildkraut J, Winer EP (1999) Attitudes, knowledge, and risk perceptions of women with breast and\/or ovarian cancer considering testing for BRCA1 and BRCA2. J Clin Oncol 17:1040\u20131046","journal-title":"J Clin Oncol"},{"key":"9706_CR9","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1086\/301670","volume":"62","author":"G Parmigiani","year":"1998","unstructured":"Parmigiani G, Berry DA, Aguilar O (1998) Determining carrier probabilities for breast cancer\u2013susceptibility genes BRCA1 and BRCA2. Am J Hum Genet 62:145\u2013158","journal-title":"Am J Hum Genet"},{"key":"9706_CR10","first-page":"173","volume-title":"Case studies in bayesian statistics iv","author":"G Parmigiani","year":"1999","unstructured":"Parmigiani G, Berry DA, Iversen JE, Joellen S, Winer EP (1999) Modeling risk of breast cancer and decisions about genetic testing. In: Gatsonis C, Carlin B, Gelman A, West M, Kass RE, Carriquiry A, Verdinelli I (eds) Case studies in bayesian statistics iv. Springer, New York, pp 173\u2013268"},{"key":"9706_CR11","doi-asserted-by":"crossref","first-page":"861","DOI":"10.2105\/AJPH.2009.176651","volume":"100","author":"SL Gomez","year":"2010","unstructured":"Gomez SL, Clarke CA, Shema SJ, Chang ET, Keegan TH, Glaser SL (2010) Disparities in breast cancer survival among Asian women by ethnicity and immigrant status: a population-based study. Am J Public Health 100:861\u2013869","journal-title":"Am J Public Health"},{"key":"9706_CR12","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1186\/1471-2458-9-246","volume":"9","author":"J Pham","year":"2009","unstructured":"Pham J, Allen L, Gomez S (2009) Why do Asian-American women have lower rates of breast conserving surgery: results of a survey regarding physician perceptions. BMC Public Health 9:246","journal-title":"BMC Public Health"},{"key":"9706_CR13","first-page":"997","volume":"277","author":"W Burke","year":"1997","unstructured":"Burke W, Daly M, Garber J, Botkin J, Kahn MJ, Lynch P, McTiernan A, Offit K, Perlman J, Petersen G, Thomson E, Varricchio C (1997) Recommendations for follow-up care of individuals with an inherited predisposition to cancer. Ii. BRCA1 and BRCA2. Cancer genetics studies consortium. JAMA 277:997\u20131003","journal-title":"Cancer genetics studies consortium. JAMA"},{"key":"9706_CR14","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1056\/NEJMoa031759","volume":"351","author":"M Kriege","year":"2004","unstructured":"Kriege M, Brekelmans CTM, Boetes C, Besnard PE, Zonderland HM, Obdeijn IM, Manoliu RA, Kok T, Peterse H, Tilanus-Linthorst MMA, Muller SH, Meijer S, Oosterwijk JC, Beex LVAM, Tollenaar RAEM, de Koning HJ, Rutgers EJT, Klijn JGM (2004) Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. N Engl J Med 351:427\u2013437","journal-title":"N Engl J Med"},{"key":"9706_CR15","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1016\/S0140-6736(05)66646-9","volume":"365","author":"MO Leach","year":"2005","unstructured":"Leach MO, Boggis CR, Dixon AK, Easton DF, Eeles RA, Evans DG, Gilbert FJ, Griebsch I, Hoff RJ, Kessar P, Lakhani SR, Moss SM, Nerurkar A, Padhani AR, Pointon LJ, Thompson D, Warren RM, Group MS (2005) Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (maribs). Lancet 365:1769\u20131778","journal-title":"Lancet"},{"key":"9706_CR16","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1001\/jama.292.11.1317","volume":"292","author":"E Warner","year":"2004","unstructured":"Warner E, Plewes DB, Hill KA, Causer PA, Zubovits JT, Jong RA, Cutrara MR, DeBoer G, Yaffe MJ, Messner SJ, Meschino WS, Piron CA, Narod SA (2004) Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination. JAMA 292:1317\u20131325","journal-title":"JAMA"},{"key":"9706_CR17","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1006\/gyno.1994.1333","volume":"55","author":"National institutes of health consensus development conference statement","year":"1994","unstructured":"National institutes of health consensus development conference statement (1994) Ovarian cancer: screening, treatment, and follow-up. Gynecol Oncol 55:S4\u201314","journal-title":"Gynecol Oncol"},{"key":"9706_CR18","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1080\/j.1600-0412.1999.781013.x","volume":"78","author":"A D\u00f8rum","year":"1999","unstructured":"D\u00f8rum A, Heimdal K, L\u00f8vslett K, Kristensen G, Hansen LJ, Sandvei R, Schiefloe A, Hagen B, Himmelmann A, Jerve F, Shetelig K, Fjaerestad I, Trop\u00e9 C, M\u00f8ller P (1999) Prospectively detected cancer in familial breast\/ovarian cancer screening. Acta Obstet Gynecol Scand 78:906\u2013911","journal-title":"Acta Obstet Gynecol Scand"},{"key":"9706_CR19","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1093\/jnci\/94.23.1773","volume":"94","author":"SA Narod","year":"2002","unstructured":"Narod SA, Dub\u00e9 MP, Klijn J, Lubinski J, Lynch HT, Ghadirian P, Provencher D, Heimdal K, Moller P, Robson M, Offit K, Isaacs C, Weber B, Friedman E, Gershoni-Baruch R, Rennert G, Pasini B, Wagner T, Daly M, Garber JE, Neuhausen SL, Ainsworth P, Olsson H, Evans G, Osborne M, Couch F, Foulkes WD, Warner E, Kim-Sing C, Olopade O, Tung N, Saal HM, Weitzel J, Merajver S, Gauthier-Villars M, Jernstrom H, Sun P, Brunet JS (2002) Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. J Natl Cancer Inst 94:1773\u20131779","journal-title":"J Natl Cancer Inst"},{"key":"9706_CR20","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1586\/14737140.9.1.51","volume":"9","author":"VG Vogel","year":"2009","unstructured":"Vogel VG (2009) The NSABP study of tamoxifen and raloxifene (star) trial. Expert Rev Anticancer Ther 9:51\u201360","journal-title":"Expert Rev Anticancer Ther"},{"key":"9706_CR21","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.brachy.2008.11.013","volume":"8","author":"S Brown","year":"2009","unstructured":"Brown S, McLaughlin M, Pope K, Haile K, Hughes L, Israel PZ (2009) Initial radiation experience evaluating early tolerance and toxicities in patients undergoing accelerated partial breast irradiation using the contura multi-lumen balloon breast brachytherapy catheter. Brachytherapy 8:227\u2013233","journal-title":"Brachytherapy"},{"key":"9706_CR22","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1093\/jnci\/dji372","volume":"97","author":"B Fisher","year":"2005","unstructured":"Fisher B, Costantino JP, Wickerham DL, Cecchini RS, Cronin WM, Robidoux A, Bevers TB, Kavanah MT, Atkins JN, Margolese RG, Runowicz CD, James JM, Ford LG, Wolmark N (2005) Tamoxifen for the prevention of breast cancer: current status of the national surgical adjuvant breast and bowel project p-1 study. J Natl Cancer Inst 97:1652\u20131662","journal-title":"J Natl Cancer Inst"},{"key":"9706_CR23","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S1548-5315(11)70262-5","volume":"6","author":"R Nusbaum","year":"2009","unstructured":"Nusbaum R, Peshkin BN, DeMarco TA, Goodenberger M (2009) BRCA1\/2 testing in patients with newly diagnosed breast cancer. Community Oncol 6:367\u2013371","journal-title":"Community Oncol"},{"key":"9706_CR24","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/ijc.22817","volume":"121","author":"MJ Bermejo-P\u00e9rez","year":"2007","unstructured":"Bermejo-P\u00e9rez MJ, M\u00e1rquez-Calder\u00f3n S, Llanos-M\u00e9ndez A (2007) Effectiveness of preventive interventions in BRCA1\/2 gene mutation carriers: a systematic review. Int J Cancer 121:225\u2013231","journal-title":"Int J Cancer"},{"key":"9706_CR25","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1200\/JCO.2004.04.188","volume":"22","author":"TR Rebbeck","year":"2004","unstructured":"Rebbeck TR, Friebel T, Lynch HT, Neuhausen SL, van \u2018t Veer L, Garber JE, Evans GR, Narod SA, Isaacs C, Matloff E, Daly MB, Olopade OI, Weber BL (2004) Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the prose study group. J Clin Oncol 22:1055\u20131062","journal-title":"J Clin Oncol"},{"key":"9706_CR26","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1056\/NEJM200107193450301","volume":"345","author":"H Meijers-Heijboer","year":"2001","unstructured":"Meijers-Heijboer H, van Geel B, van Putten WL, Henzen-Logmans SC, Seynaeve C, Menke-Pluymers MB, Bartels CC, Verhoog LC, van den Ouweland AM, Niermeijer MF, Brekelmans CT, Klijn JG (2001) Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation. N Engl J Med 345:159\u2013164","journal-title":"N Engl J Med"},{"key":"9706_CR27","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1056\/NEJMoa020119","volume":"346","author":"ND Kauff","year":"2002","unstructured":"Kauff ND, Satagopan JM, Robson ME, Scheuer L, Hensley M, Hudis CA, Ellis NA, Boyd J, Borgen PI, Barakat RR, Norton L, Castiel M, Nafa K, Offit K (2002) Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation. N Engl J Med 346:1609\u20131615","journal-title":"N Engl J Med"},{"key":"9706_CR28","doi-asserted-by":"crossref","unstructured":"Society of Gynecologic Oncologists Clinical Practice Committee (2005) Society of gynecologic oncologists clinical practice committee statement on prophylactic salpingo-oophorectomy. Gynecol Oncol 98:179\u2013181","DOI":"10.1016\/j.ygyno.2005.05.002"},{"key":"9706_CR29","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1245\/ASO.2004.09.910","volume":"11","author":"NJ Agnantis","year":"2004","unstructured":"Agnantis NJ, Paraskevaidis E, Roukos D (2004) Preventing breast, ovarian cancer in BRCA carriers: rational of prophylactic surgery and promises of surveillance. Ann Surg Oncol 11:1030\u20131034","journal-title":"Ann Surg Oncol"},{"key":"9706_CR30","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1245\/s10434-010-1136-7","volume":"17","author":"JC Boughey","year":"2010","unstructured":"Boughey JC, Hoskin TL, Degnim AC, Sellers TA, Johnson JL, Kasner MJ, Hartmann LC, Frost MH (2010) Contralateral prophylactic mastectomy is associated with a survival advantage in high-risk women with a personal history of breast cancer. Ann Surg Oncol 17:2702\u20132709","journal-title":"Ann Surg Oncol"},{"key":"9706_CR31","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1002\/cncr.20617","volume":"101","author":"K Goldflam","year":"2004","unstructured":"Goldflam K, Hunt KK, Gershenwald JE, Singletary SE, Mirza N, Kuerer HM, Babiera GV, Ames FC, Ross MI, Feig BW, Sahin AA, Arun B, Meric-Bernstam F (2004) Contralateral prophylactic mastectomy: predictors of significant histologic findings. Cancer 101:1977\u20131986","journal-title":"Cancer"},{"key":"9706_CR32","doi-asserted-by":"crossref","first-page":"4275","DOI":"10.1200\/JCO.2005.10.080","volume":"23","author":"LJ Herrinton","year":"2005","unstructured":"Herrinton LJ, Barlow WE, Yu O, Geiger AM, Elmore JG, Barton MB, Harris EL, Rolnick S, Pardee R, Husson G, Macedo A, Fletcher SW (2005) Efficacy of prophylactic mastectomy in women with unilateral breast cancer: a cancer research network project. J Clin Oncol 23:4275\u20134286","journal-title":"J Clin Oncol"},{"key":"9706_CR33","doi-asserted-by":"crossref","first-page":"3938","DOI":"10.1200\/JCO.2001.19.19.3938","volume":"19","author":"SK McDonnell","year":"2001","unstructured":"McDonnell SK, Schaid DJ, Myers JL, Grant CS, Donohue JH, Woods JE, Frost MH, Johnson JL, Sitta DL, Slezak JM, Crotty TB, Jenkins RB, Sellers TA, Hartmann LC (2001) Efficacy of contralateral prophylactic mastectomy in women with a personal and family history of breast cancer. J Clin Oncol 19:3938\u20133943","journal-title":"J Clin Oncol"},{"key":"9706_CR34","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/sj.bjc.6602703","volume":"93","author":"TC Sprundel van","year":"2005","unstructured":"van Sprundel TC, Schmidt MK, Rookus MA, Brohet R, van Asperen CJ, Rutgers EJ, Van\u2019t Veer LJ, Tollenaar RA (2005) Risk reduction of contralateral breast cancer and survival after contralateral prophylactic mastectomy in BRCA1 or BRCA2 mutation carriers. Br J Cancer 93:287\u2013292","journal-title":"Br J Cancer"},{"key":"9706_CR35","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0002-9610(00)00505-5","volume":"180","author":"EA Peralta","year":"2000","unstructured":"Peralta EA, Ellenhorn JD, Wagman LD, Dagis A, Andersen JS, Chu DZ (2000) Contralateral prophylactic mastectomy improves the outcome of selected patients undergoing mastectomy for breast cancer. Am J Surg 180:439\u2013445","journal-title":"Am J Surg"},{"key":"9706_CR36","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s10897-007-9100-9","volume":"16","author":"P Bennett","year":"2007","unstructured":"Bennett P, Wilkinson C, Turner J, Griffith G, France B, Brain K, Gray J (2007) The impact of breast cancer genetic risk assessment on intentions to perform cancer surveillance behaviors. J Genet Couns 16:617\u2013623","journal-title":"J Genet Couns"},{"key":"9706_CR37","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1006\/pmed.2000.0684","volume":"31","author":"C Lerman","year":"2000","unstructured":"Lerman C, Hughes C, Croyle RT, Main D, Durham C, Snyder C, Bonney A, Lynch JF, Narod SA, Lynch HT (2000) Prophylactic surgery decisions and surveillance practices one year following BRCA1\/2 testing. Prev Med 31:75\u201380","journal-title":"Prev Med"},{"key":"9706_CR38","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/ajmg.a.10102","volume":"118A","author":"JR Botkin","year":"2003","unstructured":"Botkin JR, Smith KR, Croyle RT, Baty BJ, Wylie JE, Dutson D, Chan A, Hamann HA, Lerman C, McDonald J, Venne V, Ward JH, Lyon E (2003) Genetic testing for a BRCA1 mutation: prophylactic surgery and screening behavior in women 2\u00a0years post testing. Am J Med Genet A 118A:201\u2013209","journal-title":"Am J Med Genet A"},{"key":"9706_CR39","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1200\/JCO.2003.09.052","volume":"21","author":"H Meijers-Heijboer","year":"2003","unstructured":"Meijers-Heijboer H, Brekelmans CT, Menke-Pluymers M, Seynaeve C, Baalbergen A, Burger C, Crepin E, van den Ouweland AW, van Geel B, Klijn JG (2003) Use of genetic testing and prophylactic mastectomy and oophorectomy in women with breast or ovarian cancer from families with a BRCA1 or BRCA2 mutation. J Clin Oncol 21:1675\u20131681","journal-title":"J Clin Oncol"},{"key":"9706_CR40","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0002-9610(01)00603-1","volume":"181","author":"KT Morris","year":"2001","unstructured":"Morris KT, Johnson N, Krasikov N, Allen M, Dorsey P (2001) Genetic counseling impacts decision for prophylactic surgery for patients perceived to be at high risk for breast cancer. Am J Surg 181:431\u2013433","journal-title":"Am J Surg"},{"key":"9706_CR41","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1089\/gte.2005.9.167","volume":"9","author":"M Watson","year":"2005","unstructured":"Watson M, Kash KM, Homewood J, Ebbs S, Murday V, Eeles R (2005) Does genetic counseling have any impact on management of breast cancer risk? Genet Test 9:167\u2013174","journal-title":"Genet Test"},{"key":"9706_CR42","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1007\/s00268-008-9589-6","volume":"32","author":"A Kwong","year":"2008","unstructured":"Kwong A, Cheung P, Chan S, Lau S (2008) Breast cancer in Chinese women younger than age 40: are they different from their older counterparts? World J Surg 32:2554\u20132561","journal-title":"World J Surg"},{"key":"9706_CR43","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s10689-007-9155-7","volume":"7","author":"A Kwong","year":"2008","unstructured":"Kwong A, Wong L, Chan K, Ma E, Khoo U, Ford J (2008) Characterization of the pathogenic mechanism of a novel BRCA2 variant in a Chinese family. Fam Cancer 7:125\u2013133","journal-title":"Fam Cancer"},{"key":"9706_CR44","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s11568-010-9136-z","volume":"3","author":"A Kwong","year":"2009","unstructured":"Kwong A, Wong LP, Wong HN, Law FB, Ng EK, Tang YH, Chan WK, Suen DT, Choi C, Ho LS, Kwan KH, Poon M, Wong TT, Chan K, Chan SW, Ying MW, Chan WC, Ma ES, Ford JM, West DW (2009) Clinical and pathological characteristics of Chinese patients with BRCA related breast cancer. Hugo J 3:63\u201376","journal-title":"Hugo J"},{"key":"9706_CR45","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1002\/1097-0142(20010815)92:4<959::AID-CNCR1406>3.0.CO;2-V","volume":"92","author":"CM Julian-Reynier","year":"2001","unstructured":"Julian-Reynier CM, Bouchard LJ, Evans DG, Eisinger FA, Foulkes WD, Kerr B, Blancquaert IR, Moatti JP, Sobol HH (2001) Women\u2019s attitudes toward preventive strategies for hereditary breast or ovarian carcinoma differ from one country to another: differences among English, French, and Canadian women. Cancer 92:959\u2013968","journal-title":"Cancer"},{"key":"9706_CR46","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1111\/j.1365-2702.2011.03884.x","volume":"21","author":"C-F Ku","year":"2012","unstructured":"Ku C-F, Koo M (2012) Association of distress symptoms and use of complementary medicine among patients with cancer. J Clin Nurs 21:736\u2013744","journal-title":"J Clin Nurs"},{"key":"9706_CR47","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1089\/acm.2008.0039","volume":"14","author":"C Zhi","year":"2008","unstructured":"Zhi C, Kai G, Ying Z, Wei Z, Wei L, Xiao OuS (2008) The use of complementary and alternative medicine among Chinese women with breast cancer. J Altern Complement Med 14:1049\u20131055","journal-title":"J Altern Complement Med"},{"key":"9706_CR48","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1207\/s15327914nc5402_1","volume":"54","author":"A Alamian","year":"2006","unstructured":"Alamian A, Rouleau I, Simard J, Dorval M (2006) Use of dietary supplements among women at high risk of hereditary breast and ovarian cancer (HBOC) tested for cancer susceptibility. Nutr Cancer 54:157\u2013165","journal-title":"Nutr Cancer"},{"key":"9706_CR49","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s10549-004-3779-1","volume":"90","author":"E Rakovitch","year":"2005","unstructured":"Rakovitch E, Pignol J-P, Chartier C, Ezer M, Verma S, Dranitsaris G, Clemons M (2005) Complementary and alternative medicine use is associated with an increased perception of breast cancer risk and death. Breast Cancer Res Treat 90:139\u2013148","journal-title":"Breast Cancer Res Treat"},{"key":"9706_CR50","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1007\/s00268-010-0477-5","volume":"34","author":"A Kwong","year":"2010","unstructured":"Kwong A, Wong CH, Shea C, Suen DT, Choi CL (2010) Choice of management of southern Chinese BRCA mutation carriers. World J Surg 34:1416\u20131426","journal-title":"World J Surg"}],"container-title":["Familial Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-014-9706-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10689-014-9706-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-014-9706-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T07:25:29Z","timestamp":1565249129000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10689-014-9706-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3,13]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["9706"],"URL":"https:\/\/doi.org\/10.1007\/s10689-014-9706-7","relation":{},"ISSN":["1389-9600","1573-7292"],"issn-type":[{"value":"1389-9600","type":"print"},{"value":"1573-7292","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,13]]}}}